Intercept Pharma (ICPT) –
-
Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC
-
Form 15-12G INTERCEPT PHARMACEUTICAL
-
Form EFFECT INTERCEPT PHARMACEUTICAL
-
Form EFFECT INTERCEPT PHARMACEUTICAL
-
Form EFFECT INTERCEPT PHARMACEUTICAL
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: AKKARAJU SRINIVAS
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Venezia Rocco
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Berrey M Michelle
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Fundaro Paolo
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Richardson Linda M
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Benatti Luca
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: SBLENDORIO GLENN
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Miller-Rich Nancy
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: SANTINI GINO
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: ROSA-BJORKESON DAGMAR
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Gottesdiener Keith Michael
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Ford David A
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Freedberg Jared
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: BRADBURY DANIEL
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Durso Jerome Benedict
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Pruzanski Mark
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 08 Filed by: Saik Andrew
-
Form 8-K INTERCEPT PHARMACEUTICAL For: Nov 08
-
Form POS AM INTERCEPT PHARMACEUTICAL
-
Form POS AM INTERCEPT PHARMACEUTICAL
-
Form POS AM INTERCEPT PHARMACEUTICAL
-
Form S-8 POS INTERCEPT PHARMACEUTICAL
-
Form S-8 POS INTERCEPT PHARMACEUTICAL
-
Form S-8 POS INTERCEPT PHARMACEUTICAL
-
Form S-8 POS INTERCEPT PHARMACEUTICAL
-
Form S-8 POS INTERCEPT PHARMACEUTICAL
-
Form S-8 POS INTERCEPT PHARMACEUTICAL
-
Form S-8 POS INTERCEPT PHARMACEUTICAL
-
Form S-8 POS INTERCEPT PHARMACEUTICAL
-
Form S-8 POS INTERCEPT PHARMACEUTICAL
-
Form 25-NSE INTERCEPT PHARMACEUTICAL Filed by: Nasdaq Stock Market LLC
-
Form SC 14D9/A INTERCEPT PHARMACEUTICAL Filed by: INTERCEPT PHARMACEUTICALS, INC.
-
Form SC TO-T/A INTERCEPT PHARMACEUTICAL Filed by: Alfasigma S.p.A.
-
Alfasigma S.p.A. successfully completes tender offer for all outstanding shares of common stock of Intercept Pharmaceuticals, Inc.
-
Form 10-Q INTERCEPT PHARMACEUTICAL For: Sep 30
-
Form 4 INTERCEPT PHARMACEUTICAL For: Nov 01 Filed by: Freedberg Jared
-
Form SC TO-T/A INTERCEPT PHARMACEUTICAL Filed by: Alfasigma S.p.A.
-
Form SC 14D9/A INTERCEPT PHARMACEUTICAL Filed by: INTERCEPT PHARMACEUTICALS, INC.
-
Form SC TO-T/A INTERCEPT PHARMACEUTICAL Filed by: Alfasigma S.p.A.
-
Alfasigma S.p.A. Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Pending Acquisition of Intercept Pharmaceuticals, Inc.
-
Form SC 14D9/A INTERCEPT PHARMACEUTICAL Filed by: INTERCEPT PHARMACEUTICALS, INC.
-
Persephone Biosciences Appoints Daniel Bradbury as Chair of the Board of Directors
-
Form SC TO-T/A INTERCEPT PHARMACEUTICAL Filed by: Alfasigma S.p.A.
-
Form SC 14D9/A INTERCEPT PHARMACEUTICAL Filed by: INTERCEPT PHARMACEUTICALS, INC.
-
Increasing unusual option volume: ICPT FOLD IHI SAVE GRAB
Back to ICPT Stock Lookup